GAST and type 2 diabetes mellitus: Singh et al[13] evaluated the effect of pantoprazole therapy on glucose-insulin homeostasis in patients with T2DM and showed that 12 weeks of pantoprazole therapy significantly increased gastrin and insulin levels and reduced HbA1c levels.